Qiagen Nv Sample Contracts

QIAGEN N.V. CHANGE IN CONTROL AGREEMENT
Change in Control Agreement • March 31st, 2003 • Qiagen Nv • Biological products, (no disgnostic substances)
Sample 1Sample 2Sample 3See All (607)
AutoNDA by SimpleDocs
ARTICLE 1 THE MERGER
Agreement and Plan of Merger • March 31st, 2003 • Qiagen Nv • Biological products, (no disgnostic substances) • Delaware
Sample 1Sample 2Sample 3See All (459)
AGREEMENT on
Agreement • March 31st, 2003 • Qiagen Nv • Biological products, (no disgnostic substances)
Sample 1Sample 2Sample 3See All (458)
DEUTSCHE BANK LUXEMBOURG S.A. as Note Registrar, Transfer Agent and Authentication Agent INDENTURE
Qiagen Nv • March 2nd, 2015 • Biological products, (no disgnostic substances) • New York

INDENTURE dated as of March 19, 2014 among QIAGEN N.V., as issuer (the “Company”), and Deutsche Trustee Company Limited, as Trustee, Deutsche Bank AG, London Branch, as Paying Agent and Conversion Agent, and Deutsche Bank Luxembourg S.A., as Note Registrar and Authentication Agent.

Sample 1Sample 2Sample 3See All (13)
by and between
Managing Director Agreement • March 31st, 2003 • Qiagen Nv • Biological products, (no disgnostic substances)
Sample 1Sample 2Sample 3See All (6)
SUBJECT: Warrant Transaction Reference Number(s): [__________]
Letter Agreement • March 6th, 2019 • Qiagen Nv • Biological products, (no disgnostic substances) • New York

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Transaction entered into between [ ] (“Dealer”) and Qiagen N.V. (“Counterparty”) on the Trade Date specified below (the “Transaction”). This Confirmation constitutes a “Confirmation” as referred to in the Agreement specified below.

Sample 1Sample 2Sample 3See All (4)
by and between
Employment Agreement • March 31st, 2003 • Qiagen Nv • Biological products, (no disgnostic substances)
Sample 1Sample 2Sample 3See All (4)
CONFIDENTIAL AND PRIVILEGED EXECUTION VERSION BUSINESS COMBINATION AGREEMENT
Business Combination Agreement • March 6th, 2020 • Qiagen N.V. • Biological products, (no disgnostic substances)
Sample 1Sample 2Sample 3
AMENDMENT NO. 1 TO BUSINESS COMBINATION AGREEMENT
Business Combination Agreement • July 16th, 2020 • Qiagen N.V. • Biological products, (no disgnostic substances)

This AMENDMENT NO. 1 TO BUSINESS COMBINATION AGREEMENT (this “Amendment”), dated as of July 16, 2020, is by and between Thermo Fisher Scientific Inc., a Delaware corporation (“Buyer”), and QIAGEN N.V., a public limited liability company (naamloze vennootschap) incorporated under the laws of the Netherlands with its corporate seat in Venlo, The Netherlands, Trade Register number 12036979 (the “Company”).

Sample 1Sample 2Sample 3
by and between QIAGEN, Auf dem Wolf 39, 4052 Basel
Employment Agreement • March 31st, 2003 • Qiagen Nv • Biological products, (no disgnostic substances)
Sample 1Sample 2
Exhibit 4.14 EMPLOYMENT AGREEMENT THE UNDERSIGNED: 1. The public limited liability company QIAGEN N.V., having its registered office at Spoorstraat 42 - 52, NL - Venlo, in this matter duly represented by Mr. Metin Colpan, hereinafter to be referred to...
Employment Agreement • March 31st, 2003 • Qiagen Nv • Biological products, (no disgnostic substances)
Sample 1Sample 2
FACSIMILE: 31 77 355 6640
Qiagen Nv • March 6th, 2019 • Biological products, (no disgnostic substances) • New York

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Transaction entered into between [ ] (“Dealer”) and Qiagen N.V. (“Counterparty”) on the Trade Date specified below (the “Transaction”). This Confirmation constitutes a “Confirmation” as referred to in the Agreement specified below.

Sample 1Sample 2
Credit contract for a Club Deal between
Qiagen Nv • April 2nd, 2002 • Biological products, (no disgnostic substances)
Sample 1Sample 2
FACSIMILE: 31 77 355 6640
Letter Agreement • March 2nd, 2015 • Qiagen Nv • Biological products, (no disgnostic substances) • New York

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Transaction entered into between [ ] (“Dealer”) and Qiagen N.V. (“Counterparty”) on the Trade Date specified below (the “Transaction”). This Confirmation constitutes a “Confirmation” as referred to in the Agreement specified below.

Sample 1Sample 2
QIAGEN N.V. CHANGE IN CONTROL AGREEMENT
Change in Control Agreement • April 19th, 2005 • Qiagen Nv • Biological products, (no disgnostic substances)

This Agreement is entered into as of the 30th day of September, 2003 by and between QIAGEN North American Holdings Inc., a corporation organized under the laws of the United States (the “Company”) and Roland Sackers (the “Executive”).

Sample 1
PURCHASE AGENT AGREEMENT
Purchase Agent Agreement • March 2nd, 2015 • Qiagen Nv • Biological products, (no disgnostic substances) • New York

QIAGEN Euro Finance (Luxembourg) S.A., a Luxembourg corporation (the “Purchaser”) and a wholly-owned subsidiary of QIAGEN N.V., a Dutch corporation (the “Company”), intends to invite holders of its outstanding U.S.$300,000,000 3.25% Senior Convertible Notes due 2026 (ISIN: XS0254367179) (the “2026 Notes”) that are eligible to participate in the Invitation (as defined below) pursuant to the Invitation to Sell Term Sheet (the “Invited Holders”) to sell their 2026 Notes (the “Invitation”).

Sample 1
Exhibit 2.6 Third Supplement
Qiagen Nv • November 15th, 2002 • Biological products, (no disgnostic substances)
Sample 1
Re: Employment Agreement
Qiagen Nv • April 19th, 2005 • Biological products, (no disgnostic substances) • Maryland

This letter is to confirm our understanding with respect to your employment in the United States by QIAGEN N.V., QIAGEN GmbH, and QIAGEN North American Holding (collectively, the “Company”) for the period of calendar year 2004. In consideration of the mutual promises and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, we have agreed as follows:

Sample 1
Credit contract for a Club Deal between
Qiagen Nv • April 19th, 2005 • Biological products, (no disgnostic substances)
Sample 1
AMENDMENT NO. 1 TO AGREEMENT IN CONNECTION WITH THE DELIVERY OF ORDINARY SHARES IN THE SHARE CAPITAL OF QIAGEN N.V. PURSUANT TO CONVERTIBLE NOTES DUE 2024 ISSUED BY QIAGEN FINANCE (LUXEMBOURG) S.A.
Qiagen Nv • April 2nd, 2007 • Biological products, (no disgnostic substances) • New York
Sample 1
Dated April 27, 2020 QIAGEN N.V. Quebec B.V. NON-TENDER AGREEMENT
Agreement • May 18th, 2020 • Qiagen N.V. • Biological products, (no disgnostic substances)
Sample 1
EMPLOYMENT AGREEMENT by and between QIAGEN GmbH, Max-Volmer-Str. 4, 40724 Hilden - hereinafter QIAGEN - and Dr. Joachim Schorr - hereinafter Employee -
Employment Agreement • March 26th, 2004 • Qiagen Nv • Biological products, (no disgnostic substances)
Sample 1
AutoNDA by SimpleDocs
LEASE -4-
Lease • March 20th, 2008 • Qiagen Nv • Biological products, (no disgnostic substances) • Maryland

THIS LEASE is made as of March 2, 1998 (the “Effective Date”), by and between ARE-METROPOLITAN GROVE I, LLC, a Delaware limited liability company (“Landlord”), and DIGENE CORPORATION, a Delaware corporation (“Tenant”). Certain capitalized terms used but not otherwise defined elsewhere in this Lease shall have the meaning ascribed thereto in Section 39.

Sample 1
EMPLOYMENT AGREEMENT by and between QIAGEN N.V., Venlo, Netherlands - hereinafter QIAGEN - and Mr. Roland Sackers - hereinafter Employee -
Employment Agreement • March 26th, 2004 • Qiagen Nv • Biological products, (no disgnostic substances)
Sample 1
SUPPLEMENT TO EMPLOYMENT AGREEMENT dated June 22, 1999 by and between QIAGEN GmbH, Max-Volmer-Str. 4, 40724 Hilden - hereinafter QIAGEN - and Dr. Joachim Schorr - hereinafter Employee -
Supplement to Employment Agreement • March 26th, 2004 • Qiagen Nv • Biological products, (no disgnostic substances)
Sample 1
EMPLOYMENT AGREEMENT by and between QIAGEN GmbH, Max-Volmer-Str. 4, 40724 Hilden - hereinafter QIAGEN - and Mr. Bernd Uder - hereinafter Employee -
Employment Agreement • March 26th, 2004 • Qiagen Nv • Biological products, (no disgnostic substances)
Sample 1
Amendment No. 2 to the Consultancy Agreement between QIAGEN GmbH („Company”) and Dr. Metin Colpan („Consultant”) dated March 23, 2009
Qiagen Nv • March 17th, 2010 • Biological products, (no disgnostic substances)

Company and Consultant are parties to a Consultancy Agreement dated December 4, 2003 as amended (the “Agreement”). Both parties wish to amend the Agreement as follows:

Sample 1
AGREEMENT IN CONNECTION WITH THE DELIVERY OF ORDINARY SHARES IN THE SHARE CAPITAL OF QIAGEN N.V. PURSUANT TO CONVERTIBLE NOTES DUE 2024 ISSUED BY QIAGEN FINANCE (LUXEMBOURG) S.A.
Qiagen Nv • April 19th, 2005 • Biological products, (no disgnostic substances) • New York
Sample 1
Amendment No. 1 to the Consultancy Agreement between QIAGEN GmbH (“Company”) and Dr. Metin Colpan (“Consultant”) dated February 11, 2004
Consultancy Agreement • April 3rd, 2006 • Qiagen Nv • Biological products, (no disgnostic substances)

Company and Consultant are parties to a Consultancy Agreement dated December 4, 2003 (the “Agreement”). Both parties wish to amend the Agreement as follows:

Sample 1
EMPLOYMENT AGREEMENT by and between QIAGEN GmbH, Max-Volmer-Str. 4, 40724 Hilden - hereinafter QIAGEN - and Mr. Roland Sackers - hereinafter Employee -
Employment Agreement • March 26th, 2004 • Qiagen Nv • Biological products, (no disgnostic substances)
Sample 1
Re: Employment Agreement
Employment Agreement • May 18th, 2020 • Qiagen N.V. • Biological products, (no disgnostic substances) • Maryland

This letter is to confirm our understanding with respect to your employment in the United States by QIAGEN N.V., QIAGEN Deutschland Holding GmbH, and QIAGEN North American Holdings, Inc. (collectively, the “Company”) for the period of calendar years 2006, 2007 and 2008. In consideration of the mutual promises and covenants contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, we have agreed as follows:

Sample 1
AMENDMENT NO. 1 TO AGREEMENT IN CONNECTION WITH THE DELIVERY OF ORDINARY SHARES IN THE SHARE CAPITAL OF QIAGEN N.V. PURSUANT TO CONVERTIBLE NOTES DUE 2026 ISSUED BY QIAGEN EURO FINANCE (LUXEMBOURG) S.A.
Qiagen Nv • April 2nd, 2007 • Biological products, (no disgnostic substances) • New York
Sample 1
Exhibit 2.5 AMENDED AND RESTATED INDEMNITY DEED OF TRUST This Amended and Restated Indemnity Deed of Trust (this "Deed of Trust"), effective this 28th day of February, 2002, by and between QIAGEN Sciences, Inc., a corporation organized under the laws...
Qiagen Nv • April 2nd, 2002 • Biological products, (no disgnostic substances)
Sample 1
FOURTH AMENDMENT TO LEASE
Lease • March 20th, 2008 • Qiagen Nv • Biological products, (no disgnostic substances)

THIS FOURTH AMENDMENT TO LEASE (the “Fourth Amendment”), is made as of November 15, 2005 (the “Effective Date”), by and between ARE-METROPOLITAN GROVE I, LLC, a Delaware limited liability company (“Landlord”), and DIGENE CORPORATION, a Delaware corporation (“Tenant”).

Sample 1
Exhibit 4.8 Dated for Reference Purposes: May 16, 2001 SECOND AMENDMENT TO THE STANDARD INDUSTRIAL/COMMERCIAL SINGLE-TENANT LEASE-NET DATED MAY 15, 1996 AND THE FIRST AMENDMENT DATED FOR REFERENCE PURPOSES AS FEBRURAY 10, 1999 WHEREIN HASERJIAN BROS....
Qiagen Nv • April 2nd, 2002 • Biological products, (no disgnostic substances)

SECOND AMENDMENT TO THE STANDARD INDUSTRIAL/COMMERCIAL SINGLE-TENANT LEASE-NET DATED MAY 15, 1996 AND THE FIRST AMENDMENT DATED FOR REFERENCE PURPOSES AS FEBRURAY 10, 1999 WHEREIN HASERJIAN BROS. REALTY CO., A CALIFORNIA GENERAL PARTNERSHIP IS REFERRED TO AS LESSOR AND QIAGEN, INC., A WHOLLY OWNED SUBSIDIARY OF QIAGEN, GMBH, A GERMAN CORPORATION IS REFERRED TO AS LESSEE FOR THE PREMISES COMMONLY KNOWN AS 28159 AVENUE STANFORD, SANTA CLARITA, CALIFORNIA

Sample 1
Time is Money Join Law Insider Premium to draft better contracts faster.